Clive G Wilson, Ph.D., E.F.A.P.S., F.C.R.S.
Clive G Wilson, Ph.D., E.F.A.P.S., F.C.R.S.
CurrentEUFEPS, University of Strathclyde, Glasgow, Scotland, United Kingdom
Emailc.g.wilson@strath.ac.uk

Clive Wilson is the J. P. Todd Professor of Pharmaceutics at Strathclyde University and the immediate past president of the European Union Federation for Pharmaceutical Sciences. He remains on the steering group with responsibilities for European training policy and interactions with professional societies.

Major areas of research have been the study of the behaviour of drug formulations in man. With John Hardy in Medical Physics at Queen’s Medical Centre and later Professor Davis in Pharmacy at Nottingham, he pioneered applications of scintigraphy in the study of physiological and patho-physiological effects of transit on drug absorption following oral, nasal, pulmonary and ophthalmic delivery. These activities have continued at Glasgow and increased through a network of worldwide collaborations. The focus of the present work has also widened and his growing research group covers projects in protein stabilisation, ocular, dental and nasal drug delivery, implant technology, novel imaging and image processing. This is added to his long-standing interest in gastrointestinal physiology applied to the study of oral dosage forms. He is a consultant to several companies in pharmaceutical and allied industries including currently Allergan (USA), Aspire (USA), Ferring (Denmark), GSK (UK, USA), Kala (USA), NovaLiq (Germany), Philips Medimetrix (Science Board) and Rib-X (USA). He has published more than 160 papers, seven books and over 100 reviews and book chapters and has supervised 58 Ph.D. and 1 M.D. student. He was made a Fellow of the Controlled Release Society in June 2010 and a Fellow of the Academy of Pharmaceutical Sciences in September 2010.